Michael Jolly, MD
Interventional Cardiology · Columbus, OHNPI 1639295462
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Inari Medical, Inc. accounts for 82.8% of it on its own, with 26 other manufacturers making up the rest. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 373 payments — averaging $752.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$232K
- Stryker$16K
- Boston Scientific$10K
- Medtronic$6K
- W. L. Gore & Associates, Inc.$3K
- Contego Medical, Inc$3K
- plus $10K from 21 others
Across 62 payments — averaging $2364.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Surmodics, Inc.$86K
- Vesper Medical$58K
- Philips North America LLC$2K
What the payments were for
- Consulting fees$153,40855%
- Speaking & faculty fees$96,06634%
- Travel & lodging$18,5757%
- Food & beverage$12,4674%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 181 | $232,167 |
| Stryker | 7 | $16,352 |
| Boston Scientific | 25 | $9,898 |
| Medtronic(2 entities) | 15 | $5,659 |
| W. L. Gore & Associates, Inc. | 31 | $3,481 |
| Contego Medical, Inc | 2 | $2,774 |
| Inquis Medical, Inc. | 3 | $2,500 |
| Vesper Medical | 3 | $1,541 |
| Angiodynamics, Inc. | 5 | $1,197 |
| Silk Road Medical, Inc. | 6 | $937 |
| Abbott | 21 | $688 |
| Biotronik Inc. | 40 | $583 |
| Penumbra, Inc. | 4 | $533 |
| Philips North America LLC | 2 | $460 |
| Cook Medical LLC | 6 | $444 |
| Abiomed | 3 | $336 |
| Argon Medical Devices, Inc. | 1 | $211 |
| Mercator Medsystems, Inc. | 1 | $200 |
| Cardiovascular Systems Inc. | 3 | $199 |
| Centerline Biomedical Inc. | 1 | $173 |
| AbbVie | 3 | $55 |
| Edwards Lifesciences | 3 | $46 |
| Novo Nordisk | 2 | $37 |
| Imperative Care, Inc | 2 | $30 |
| Teleflex LLC | 1 | $16 |
| Siemens Medical Solutions USA, Inc. | 1 | $13 |
| Cardinal Health 200 LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$191,920
- FLOWTRIEVER CATHETER, S$137,372
- FlowTriever$81,714
- ClotTriever$81,714
- GENERAL - THERAPIES$6,563
- Aventus$2,500
- Neuroguard$2,112
- AVVIGO Guidance System$1,875
- Product in Development$1,835
- DUO Venous Stent System$1,500
- AngioVac$1,024
- ENROUTE Transcarotid Neuroprotection System$828
- ENROUTE Transcarotid Stent System$828
- ENHANCE Transcarotid Peripheral Access Kit$828
- ENROUTE 0.014 Guidewire$828
- GENERAL VASCULAR INTERVENTION$572
- Indigo System$495
- GORE TAG Thoracic Endoprosthesis$449
- (6554) Peripheral Vascular Undivided$400
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$255
How this compares
$280,542 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 176 | $165,582 |
| XareltoRivaroxaban | 51 | $57,257 |
| EntrestoSacubitril/Valsartan | 28 | $23,714 |
| ClopidogrelClopidogrel Bisulfate | 232 | $2,123 |
| Atorvastatin Calcium | 213 | $1,386 |
| Cilostazol | 72 | $1,127 |
| Rosuvastatin Calcium | 92 | $963 |
| Metoprolol Succinate | 115 | $874 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 36 | $461 |
| Lisinopril | 61 | $332 |
| Carvedilol | 52 | $283 |
| Ezetimibe | 24 | $242 |
| Amlodipine Besylate | 60 | $219 |
| Furosemide | 53 | $187 |
| Nitroglycerin | 19 | $184 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Columbus
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- Timothy SmithColumbus$149K
- Christopher HuffColumbus$119K
- Joseph CampbellColumbus$114K
- Aref AmroColumbus$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.